DANOFRAN T3A 8mg 2mg / ml injectible solution medication leaflet

A04AA01 ondansetron • Alimentary tract and metabolism | Antiemetics and antinauseants | Serotonin (5ht3) antagonists

Ondansetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, or surgery. It belongs to the class of 5-HT3 serotonin receptor antagonists, working by blocking these receptors in the brain and gastrointestinal tract, thereby reducing the reflex of nausea and vomiting.

Ondansetron is administered in the form of tablets, oral solution, or injections, depending on the patient's needs. It is effective in preventing both acute and delayed nausea associated with cancer treatments or postoperative care.

Common side effects include headache, constipation, fatigue, or dizziness. In rare cases, it may cause allergic reactions or heart rhythm disturbances. It is important to use ondansetron as prescribed by a healthcare provider, and patients with heart conditions or those taking other medications should inform their doctor to avoid potential interactions.

General data about DANOFRAN T3A 8mg 2mg / ml

Substance: ondansetron

Date of last drug list: 01-07-2013

Commercial code: W08914001

Concentration: 2mg / ml

Pharmaceutical form: injectible solution

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for ondansetron

0.08mg/ml, 0.16mg/ml, 2mg/ml, 2mg/ml-2ml, 2mg/ml-4ml, 4mg, 4mg/2ml, 8mg, 8mg/4ml

Other substances similar to ondansetron